Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase

Author： Nucera E.   Schiavino D.   Sabato V.   Colagiovanni A.   Pecora V.   Rizzi A.   Aruanno A.   Milani M.   Pollastrini E.   Patriarca G.  

Publisher： Informa Healthcare

E-ISSN： 0300-7995|24|4|1147-1154

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.4, 2008-04, pp. : 1147-1154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Safety of an Ultra-Rush Immunotherapy Build-Up Schedule with Therapeutic Vaccines Containing Depigmented and Polymerized Allergen Extracts

By  

International Archives of Allergy and Immunology, Vol. 139, Iss. 2, 2006-02 ,pp. : 153-158

Karger

Access to resources Recommend Favorite

Safety and Tolerability of Ultra-Rush Induction, Less than One Hour, of Sublingual Immunotherapy in Children

By  

International Archives of Allergy and Immunology, Vol. 139, Iss. 2, 2006-02 ,pp. : 149-152

Karger

Access to resources Recommend Favorite

Immunological and clinical factors associated with adverse systemic reactions during the build‐up phase of honeybee venom immunotherapy

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 45, Iss. 10, 2015-10 ,pp. : 1579-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunological and clinical factors associated with adverse systemic reactions during the build‐up phase of honeybee venom immunotherapy

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 954-7894, Iss. 10, 2015-10 ,pp. : 1579-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Observational Study of the Safety of an Ultra-Rush Sublingual Immunotherapy Regimen to Treat Rhinitis due to House Dust Mites

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 1, 2010-07 ,pp. : 69-75

Karger

Access to resources Recommend Favorite